Zalicus Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Zalicus Pharmaceuticals Ownership

Who owns Zalicus Pharmaceuticals?

Zalicus Pharmaceuticals is owned by Taro Pharmaceuticals. It was acquired on October 14, 2015.

Zalicus Pharmaceuticals Business Overview

Where is Zalicus Pharmaceuticals headquartered?

Zalicus Pharmaceuticals is headquartered in Vancouver, British Columbia.

What sector is Zalicus Pharmaceuticals in?

Zalicus Pharmaceuticals is a life science company.

When was Zalicus Pharmaceuticals founded?

Zalicus Pharmaceuticals was founded in 2009.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.

Zalicus Pharmaceuticals Ltd.

301 - 2389 Health Sciences Mall,
Vancouver, British Columbia V6T 1Z3
Canada,
(604) 909-2530

Zalicus Pharmaceuticals Ltd. is a pharmaceutical company developer of biosimilar drugs.


 Subscribe to unlock this and 208,602
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.